{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:37:17Z","timestamp":1794652637252,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2022-00916"],"award-info":[{"award-number":["2022-00916"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2022-00916"],"award-info":[{"award-number":["2022-00916"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cerebrovascular disease is common in patients on the Lewy body (LB) continuum (dementia with Lewy bodies (DLB) and prodromal-DLB). White matter signal abnormality (WMSA) volume is higher in patients with LB than controls, both globally and in cholinergic white matter. However, it remains unknown if the higher WMSA in cholinergic white matter reflects selective cholinergic vulnerability or results from higher global WMSA. We modelled cingulate and external capsule cholinergic white matter pathways using MRI and segmented WMSA overlapping cholinergic pathways and per brain lobe. We found that patients on the LB-continuum (<jats:italic>n<\/jats:italic>\u2009=\u200933) had higher volume and proportion of WMSA in the cholinergic white matter compared to controls (<jats:italic>n<\/jats:italic>\u2009=\u200936), independent of global WMSA. Cholinergic WMSA was associated with neurodegeneration in the basal forebrain, decreased integrity of cingulate and external capsule pathways and attention and memory performance. These findings may suggest a selective vulnerability of cholinergic pathways in patients with LB.<\/jats:p>","DOI":"10.1038\/s41531-025-01118-5","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T10:29:33Z","timestamp":1755772173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum"],"prefix":"10.1038","volume":"11","author":[{"given":"Anna","family":"Rennie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Nemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cene","family":"Jerele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Rodr\u00edguez-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Montal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bejanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica G","family":"Kramberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan, D. B. et al. The prevalence and incidence of dementia with Lewy bodies: a systematic review. Can. J. Neurol. Sci. 43, S83\u2013S95 (2016).","journal-title":"Can. J. Neurol. Sci."},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JPM Kane","year":"2018","unstructured":"Kane, J. P. M. et al. Clinical prevalence of Lewy body dementia. Alzheimer\u2019s Res. Ther. 10, 19\u201319 (2018).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"1118_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones, S. A. & O\u2019Brien, J. T. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol. Med. 44, 673\u2013683 (2014).","journal-title":"Psychol. Med."},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith, I. G. et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94, 743\u2013755 (2020).","journal-title":"Neurology"},{"key":"1118_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2015.03.046","volume":"353","author":"H-E Park","year":"2015","unstructured":"Park, H.-E. et al. Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism. J. Neurol. Sci. 353, 44\u201348 (2015).","journal-title":"J. Neurol. Sci."},{"key":"1118_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/gps.4338","volume":"30","author":"H Shimada","year":"2015","unstructured":"Shimada, H. et al. Dementia with Lewy bodies can be well-differentiated from Alzheimer\u2019s disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. Int. J. Geriatr. Psychiatry 30, 1105\u20131113 (2015).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00415-014-7439-z","volume":"261","author":"MJ Grothe","year":"2014","unstructured":"Grothe, M. J. et al. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer\u2019s disease dementia. J. Neurol. 261, 1939\u20131948 (2014).","journal-title":"J. Neurol."},{"key":"1118_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/gps.4500","volume":"32","author":"SJ Colloby","year":"2017","unstructured":"Colloby, S. J., Elder, G. J., Rabee, R., O\u2019Brien, J. T. & Taylor, J.-P. Structural grey matter changes in the substantia innominata in Alzheimer\u2019s disease and dementia with Lewy bodies: a DARTEL-VBM study. Int. J. Geriatr. Psychiatry 32, 615\u2013623 (2017).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"1118_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","volume":"73","author":"H Shimada","year":"2009","unstructured":"Shimada, H. et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73, 273\u2013278 (2009).","journal-title":"Neurology"},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/brain\/awab372","volume":"145","author":"J Schumacher","year":"2022","unstructured":"Schumacher, J. et al. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain145, 1773\u20131784 (2022).","journal-title":"Brain"},{"key":"1118_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13034","author":"J Schumacher","year":"2023","unstructured":"Schumacher, J. et al. Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.13034 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.neurobiolaging.2006.02.009","volume":"28","author":"H Hanyu","year":"2007","unstructured":"Hanyu, H. et al. MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol. aging 28, 548\u2013554 (2007).","journal-title":"Neurobiol. aging"},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.14802\/jmd.11014","volume":"4","author":"HJ Kim","year":"2011","unstructured":"Kim, H. J., Lee, J. E., Shin, S. J., Sohn, Y. H. & Lee, P. H. Analysis of the substantia innominata volume in patients with Parkinson\u2019s disease with dementia, dementia with lewy bodies, and Alzheimer\u2019s disease. J. Mov. Disord. 4, 68\u201372 (2011).","journal-title":"J. Mov. Disord."},{"key":"1118_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae069","author":"N Okkels","year":"2024","unstructured":"Okkels, N. et al. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes. Brain https:\/\/doi.org\/10.1093\/brain\/awae069 (2024).","journal-title":"Brain"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00401-005-0004-1","volume":"111","author":"H Fujishiro","year":"2006","unstructured":"Fujishiro, H. et al. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies. Acta Neuropathol. 111, 109\u2013114 (2006).","journal-title":"Acta Neuropathol."},{"key":"1118_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/13607863.2022.2032601","volume":"27","author":"KE Watts","year":"2023","unstructured":"Watts, K. E., Storr, N. J., Barr, P. G. & Rajkumar, A. P. Systematic review of pharmacological interventions for people with Lewy body dementia. Aging Ment. Health 27, 203\u2013216 (2023).","journal-title":"Aging Ment. Health"},{"key":"1118_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14118","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: an up to 10-year follow-up study. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.14118 (2024).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1118_CR19","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","volume":"121","author":"NR Selden","year":"1998","unstructured":"Selden, N. R., Gitelman, D. R., Salamon-Murayama, N., Parrish, T. B. & Mesulam, M. M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain121, 2249\u20132257 (1998).","journal-title":"Brain"},{"key":"1118_CR20","doi-asserted-by":"publisher","first-page":"e1619","DOI":"10.1212\/WNL.0000000000200930","volume":"99","author":"N Cedres","year":"2022","unstructured":"Cedres, N. et al. Association of cerebrovascular and Alzheimer disease biomarkers with cholinergic white matter degeneration in cognitively unimpaired individuals. Neurology 99, e1619\u2013e1629 (2022).","journal-title":"Neurology"},{"key":"1118_CR21","doi-asserted-by":"publisher","first-page":"116607","DOI":"10.1016\/j.neuroimage.2020.116607","volume":"211","author":"M Nemy","year":"2020","unstructured":"Nemy, M. et al. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. NeuroImage211, 116607\u2013116607 (2020).","journal-title":"NeuroImage"},{"key":"1118_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf173","author":"C Jerele","year":"2025","unstructured":"Jerele, C. et al. Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaf173 (2025).","journal-title":"Brain Commun."},{"key":"1118_CR23","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/brain\/awac093","volume":"145","author":"CP Lin","year":"2022","unstructured":"Lin, C. P. et al. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer\u2019s disease. Brain145, 2869\u20132881 (2022).","journal-title":"Brain"},{"key":"1118_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnagi.2017.00047","volume":"9","author":"Q Liu","year":"2017","unstructured":"Liu, Q. et al. White matter damage in the cholinergic system contributes to cognitive impairment in subcortical vascular cognitive impairment, no dementia. Front. Aging Neurosci. 9, 47\u201347 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"1118_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac385","author":"M Nemy","year":"2022","unstructured":"Nemy, M. et al. Cholinergic white matter pathways along the Alzheimer\u2019s disease continuum. Brainhttps:\/\/doi.org\/10.1093\/brain\/awac385 (2022).","journal-title":"Brain"},{"key":"1118_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2023.09.011","volume":"132","author":"T Qiu","year":"2023","unstructured":"Qiu, T. et al. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment. Neurobiol. Aging 132, 198\u2013208 (2023).","journal-title":"Neurobiol. Aging"},{"key":"1118_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/ene.15211","volume":"29","author":"Z Hijazi","year":"2022","unstructured":"Hijazi, Z., Yassi, N., O\u2019Brien, J. T. & Watson, R. The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson\u2019s disease dementia. Eur. J. Neurol. 29, 1254\u20131265 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1118_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae290","author":"A Rennie","year":"2024","unstructured":"Rennie, A. et al. Cerebrovascular and Alzheimer\u2019s disease biomarkers in dementia with Lewy bodies and other dementias. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcae290 (2024).","journal-title":"Brain Commun."},{"key":"1118_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00131-X","author":"M Duering","year":"2023","unstructured":"Duering, M. et al. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(23)00131-X (2023).","journal-title":"Lancet Neurol."},{"key":"1118_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2016.07.003","volume":"13","author":"L Sarro","year":"2017","unstructured":"Sarro, L. et al. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 13, 257\u2013266 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1118_CR31","doi-asserted-by":"publisher","first-page":"9437","DOI":"10.1038\/s41598-017-08667-7","volume":"7","author":"D Roquet","year":"2017","unstructured":"Roquet, D. et al. Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study. Sci. Rep. 7, 9437\u20139410 (2017).","journal-title":"Sci. Rep."},{"key":"1118_CR32","doi-asserted-by":"publisher","first-page":"e846","DOI":"10.1212\/WNL.0000000000201579","volume":"100","author":"D Ferreira","year":"2023","unstructured":"Ferreira, D. et al. Cross-sectional Associations of \u03b2-Amyloid, Tau, and cerebrovascular biomarkers with neurodegeneration in probable dementia with lewy bodies. Neurology 100, e846\u2013e859 (2023).","journal-title":"Neurology"},{"key":"1118_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/mds.29763","volume":"39","author":"SY Chiu","year":"2024","unstructured":"Chiu, S. Y. et al. Longitudinal free-water changes in dementia with lewy bodies. Mov. Disord. 39, 836\u2013846 (2024).","journal-title":"Mov. Disord."},{"key":"1118_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00325-x","volume":"11","author":"YY Fathy","year":"2022","unstructured":"Fathy, Y. Y. et al. Axonal degeneration in the anterior insular cortex is associated with Alzheimer\u2019s co-pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Transl. Neurodegen. 11, 52 (2022).","journal-title":"Transl. Neurodegen."},{"key":"1118_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/brain\/awl388","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell, J. L. et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer\u2019s disease. Brain130, 708\u2013719 (2007).","journal-title":"Brain"},{"key":"1118_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2021.04.029","volume":"105","author":"D Ferreira","year":"2021","unstructured":"Ferreira, D. et al. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies. Neurobiol. Aging 105, 252\u2013261 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1118_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mds.29248","volume":"38","author":"A Habich","year":"2023","unstructured":"Habich, A., Wahlund, L. O., Westman, E., Dierks, T. & Ferreira, D. Dis-)Connected dots in dementia with lewy bodies\u2014a systematic review of connectivity studies. Mov. Disord 38, 4\u201315 (2023).","journal-title":"Mov. Disord"},{"key":"1118_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.935652","volume":"14","author":"T-Y Chen","year":"2022","unstructured":"Chen, T.-Y., Chan, P.-C., Tsai, C.-F., Wei, C.-Y. & Chiu, P.-Y. White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages. Front. Aging Neurosci. 14, 935652. https:\/\/doi.org\/10.3389\/fnagi.2022.935652 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1118_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/WAD.0000000000000585","volume":"37","author":"R Membreno","year":"2023","unstructured":"Membreno, R. et al. Regional white matter hyperintensities relate to specific cognitive abilities in older adults without dementia. Alzheimer Dis. Assoc. Disord. 37, 303\u2013309 (2023).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"1118_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101870","volume":"23","author":"V Pozorski","year":"2019","unstructured":"Pozorski, V. et al. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson\u2019s disease. NeuroImage Clin. 23, 101870. https:\/\/doi.org\/10.1016\/j.nicl.2019.101870 (2019).","journal-title":"NeuroImage Clin."},{"key":"1118_CR41","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/alz.12827","volume":"19","author":"M Coenen","year":"2023","unstructured":"Coenen, M. et al. Strategic white matter hyperintensity locations for cognitive impairment: a multicenter lesion-symptom mapping study in 3525 memory clinic patients. Alzheimer\u2019s Dement19, 2420\u20132432 (2023).","journal-title":"Alzheimer\u2019s Dement"},{"key":"1118_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"R Skogseth","year":"2017","unstructured":"Skogseth, R. et al. Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. J. Alzheimer\u2019s Dis. 59, 1139\u20131152 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1118_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/arclin\/acp038","volume":"24","author":"J Pe\u00f1a-Casanova","year":"2009","unstructured":"Pe\u00f1a-Casanova, J. et al. Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit modalities test. Arch. Clin. Neuropsychol. 24, 321\u2013341 (2009).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1118_CR44","doi-asserted-by":"crossref","unstructured":"Wechsler, D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Administration and scoring manual (The Psychological Corporation, 1997).","DOI":"10.1037\/t49755-000"},{"key":"1118_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2466\/pms.2003.97.3f.1209","volume":"97","author":"G Groth-Marnat","year":"2003","unstructured":"Groth-Marnat, G. & Baker, S. Digit span as a measure of everyday attention: a study of ecological validity. Percept. Mot. Skills 97, 1209\u20131218 (2003).","journal-title":"Percept. Mot. Skills"},{"key":"1118_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.trci.2019.09.005","volume":"5","author":"D Alcolea","year":"2019","unstructured":"Alcolea, D. et al. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: a data set for biomarker discovery and validation in neurodegenerative disorders. Alzheimer\u2019s Dement.5, 597\u2013609 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1118_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"1118_CR48","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S0028-3932(01)00055-0","volume":"39","author":"R Blesa","year":"2001","unstructured":"Blesa, R. et al. Clinical validity of the \u2018mini-mental state\u2019 for Spanish speaking communities. Neuropsychologia 39, 1150\u20131157 (2001).","journal-title":"Neuropsychologia"},{"key":"1118_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","volume":"91","author":"EC Ballinger","year":"2016","unstructured":"Ballinger, E. C., Ananth, M., Talmage, D. A. & Role, L. W. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron91, 1199\u20131218 (2016).","journal-title":"Neuron"},{"key":"1118_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/arclin\/acp041","volume":"24","author":"J Pe\u00f1a-Casanova","year":"2009","unstructured":"Pe\u00f1a-Casanova, J. et al. Spanish Multicenter Normative Studies (NEURONORMA Project): norms for the Rey\u2013Osterrieth Complex Figure (Copy and Memory), and Free and Cued Selective Reminding Test. Arch. Clin. Neuropsychol. 24, 371\u2013393 (2009).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1118_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/01688638408401233","volume":"6","author":"H Buschke","year":"1984","unstructured":"Buschke, H. Cued recall in amnesia. J. Clin. Neuropsychol. 6, 433\u2013440 (1984).","journal-title":"J. Clin. Neuropsychol."},{"key":"1118_CR52","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/acn3.50873","volume":"6","author":"D Alcolea","year":"2019","unstructured":"Alcolea, D. et al. Agreement of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease on Lumipulse. Ann. Clin. Transl. Neurol. 6, 1815\u20131824 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1118_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fninf.2013.00049","volume":"7","author":"JS Muehlboeck","year":"2014","unstructured":"Muehlboeck, J. S., Westman, E. & Simmons, A. TheHiveDB image data management and analysis framework. Front. Neuroinform. 7, 49 (2014).","journal-title":"Front. Neuroinform."},{"key":"1118_CR54","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/JAD-132345","volume":"40","author":"I Kilimann","year":"2014","unstructured":"Kilimann, I. et al. Subregional basal forebrain atrophy in Alzheimer\u2019s disease: a multicenter study. J. Alzheimer\u2019s Dis. 40, 687\u2013700 (2014).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1118_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. NeuroImage62, 782\u2013790 (2012).","journal-title":"NeuroImage"},{"key":"1118_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mrm.10609","volume":"50","author":"TEJ Behrens","year":"2003","unstructured":"Behrens, T. E. J. et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn. Reson. Med. 50, 1077\u20131088 (2003).","journal-title":"Magn. Reson. Med."},{"key":"1118_CR57","doi-asserted-by":"crossref","unstructured":"Mori, S. MRI atlas of human white matter. 1st edn, (Elsevier, 2005).","DOI":"10.1016\/B978-044451741-8\/50001-9"},{"key":"1118_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/42.906424","volume":"20","author":"Y Zhang","year":"2001","unstructured":"Zhang, Y., Brady, M. & Smith, S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. imaging 20, 45\u201357 (2001).","journal-title":"IEEE Trans. Med. imaging"},{"key":"1118_CR59","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl, B. FreeSurfer. NeuroImage62, 774\u2013781 (2012).","journal-title":"NeuroImage"},{"key":"1118_CR60","doi-asserted-by":"publisher","first-page":"894","DOI":"10.18632\/aging.102662","volume":"12","author":"N Cedres","year":"2020","unstructured":"Cedres, N. et al. Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities. Aging12, 894\u2013901 (2020).","journal-title":"Aging"},{"key":"1118_CR61","doi-asserted-by":"publisher","unstructured":"Wei, K. et al. White matter hypointensities and hyperintensities have equivalent correlations with age and CSF \u03b2-amyloid in the nondemented elderly. Brain and behavior 9, e01457-n\/a https:\/\/doi.org\/10.1002\/brb3.1457 (2019).","DOI":"10.1002\/brb3.1457"},{"key":"1118_CR62","doi-asserted-by":"publisher","first-page":"1355695","DOI":"10.3389\/fnins.2024.1355695","volume":"18","author":"R Mohanty","year":"2024","unstructured":"Mohanty, R., Ferreira, D. & Westman, E. Multi-pathological contributions toward atrophy patterns in the Alzheimer\u2019s disease continuum. Front. Neurosci. 18, 1355695\u20131355695 (2024).","journal-title":"Front. Neurosci."},{"key":"1118_CR63","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.neuroimage.2008.10.030","volume":"44","author":"DH Salat","year":"2009","unstructured":"Salat, D. H. et al. Regional white matter volume differences in nondemented aging and Alzheimer\u2019s disease. NeuroImage44, 1247\u20131258 (2009).","journal-title":"NeuroImage"},{"key":"1118_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein, A. & Tourville, J. 101 labeled brain images and a consistent human cortical labeling protocol. Front. Neurosci. 6, 171\u2013171 (2012).","journal-title":"Front. Neurosci."},{"key":"1118_CR65","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnagi.2014.00264","volume":"6","author":"O Voevodskaya","year":"2014","unstructured":"Voevodskaya, O. et al. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer\u2019s disease. Front. Aging Neurosci. 6, 264\u2013264 (2014).","journal-title":"Front. Aging Neurosci."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01118-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01118-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01118-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:37:33Z","timestamp":1757479053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01118-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01118-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.Aa. has received research support and\/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health and served as a paid consultant for H. Lundbeck, Eisai and Evonik. D.Al. participated in advisory boards from Fujirebio-Europe, Roche Diagnostics, Grifols S.A., and Lilly, and received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia, Krka Farmac\u00e9utica S.L., Zambon S.A.U., Neuraxpharm, Alter Medica, Lilly and Esteve Pharmaceuticals S.A. D.Al. declares a filed patent application (WO2019175379 A1 Markers of synaptopathy in neurodegenerative disease). D.F. consults for BioArctic and has received honoraria from Esteve.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}